Pilot study of ofloxacin and interferon-alpha combination therapy for chronic hepatitis C without sustained response to initial interferon administration

Canadian Journal of Gastroenterology

Volumn 11, Issue 6, 1997, Pages 507-511

  Komatsu, Masafumi ^a   Ishii, Tohru ^a   Ono, Tsuyoshi ^a   Hoshino, Takao ^a   Kuramitsu, Tomoyuki ^a   Goto, Takashi ^a   Fujii, Tomoo ^a   Toyoshima, Itaru ^a   Chiba, Mitsuro ^a   Masamune, Osamu ^a  

^a AKITA UNIVERSITY   (Japan)

Author keywords

Chronic hepatitis C; Combination therapy; Interferon alpha; Ofloxacin

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA INTERFERON; ALPHA2B INTERFERON; ANTIBIOTIC AGENT; ANTIVIRUS AGENT; OFLOXACIN; VIRUS RNA;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CHRONIC HEPATITIS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DRUG EFFICACY; FEMALE; HEPATITIS C; HUMAN; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0030870657     PISSN: 08357900     EISSN: None     Source Type: Journal    
DOI: 10.1155/1997/627297     Document Type: Article

References (2)

1. Hoofnagle JH, Mullen KD, Jones DB, et al. Treatment of chronic non-A, non-B hepatitis with recombinant human alpha interferon. N Engl J Med 1986;315:1575-8.
2. Di Bisceglie AM, Martin P, Kassiandies C, et al. Recombinant interferon alpha therapy for chronic hepatitis C. A randomized, double-blind, placebo-controlled trial. N Engl J Med 1989;321:1506-10.